Cresco Labs, a multistate cannabis operator based in Chicago, said it has secured up to $200 million in debt funding from a syndicate of lenders.
The money is earmarked to:
- Expand operations in Illinois, where it’s based.
- Finance pending acquisitions
- Fund other growth initiatives.
The company expects to draw down up to an initial $100 million of the total by the end of January.
The remaining maximum of $100 million will be a mutually agreed-upon figure with the lenders.
The debt financing was secured with a number of investors, including institutional lenders as well as members of the management team at Cresco and its board.
The interest rate for the initial amount of up to $100 million is roughly 12.7% to 13.2%, depending on payback terms.
While capital is in short supply in the marijuana industry, Cresco’s deal shows that well-run cannabis companies can still access money.
Cresco’s move follows that of another multistate operator, Massachusetts-based Curaleaf, which last week closed up to a $300 million debt offering.
Cresco trades on the Canadian Securities Exchange as CL.
– Nick Thomas
For analysis and in-depth looks at the investment trends and deals driving the cannabis industry forward, sign up for our premium subscription service, Investor Intelligence.
Written by Nick Thomas.
View the original article at here.
Marijuana Business Daily